Alcinous Pharmaceuticals, Inc.

New Filing
CIK: 0001809300·Pharmaceuticals·DELAWARE·Filed: Apr 16, 2020
Total Offering

$600,000

Amount Sold

$100,000

Investors

2

First Sale

Apr 3, 2020

Offering Details

Type
Equity, Debt, Option to Acquire, Security to be Acquired
Exemptions
Rule 506(b)
Entity Type
Corporation
Year Incorporated
2020
Non-Accredited Investors
No

Related Persons

NameRole
Nicholas A. DaSilva
Related Person
Kenneth N. Rose
Related Person
Benjamin J. Barlock
Related Person

Company

Alcinous Pharmaceuticals, Inc.

14 BICKNELL AVENUE

RUMFORD, RI, 02916

4015293190

SEC Filing

0001809300-20-000001

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free
Alcinous Pharmaceuticals, Inc. Form D Filing — $600,000 | FilingFlow